Xencor | XNCR - Pasivo Circulante

Precio De Mercado
12.13
Cambio Diario
0.01 0.08%
Mensual
4.84%
Anual
-8.11%
Q1 Expectativa
11.64




Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Biogen USD 3.35B 59.4M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Cytokinetics USD 202.45M 60.31M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
MacroGenics USD 43.11M 1.36M 2025-12
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Xencor USD 95.91M 9.42M 2025-12